The largest database of trusted experimental protocols

Microtainer sst blood collection tubes

Manufactured by BD
Sourced in United States

BD Microtainer SST blood collection tubes are used for the collection and separation of serum samples from whole blood. These tubes contain a gel separator that allows for the separation of serum from the blood cells after centrifugation.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using microtainer sst blood collection tubes

1

SARS-CoV-2 S Protein Vaccination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Banked serum from 10–12-month-old female BALB/c mice vaccinated with a prime & boost regimen (boost 4 weeks post-prime, final bleed 4 weeks post-boost) was utilized for assessment of neutralizing antibody evasion. Mice were vaccinated intramuscularly into each thigh with 25 μL (50 μL total) of a PBS solution containing 1 μg S2P protein with 250 μg Aluminum Hydroxide adjuvant. The S2P spike stabilized protein vaccine included the Wuhan SARS-CoV-2 S gene sequence. After vaccination and boost, blood was collected either from non-terminal cheek bleeds or terminal thoracic aorta dissection into BD Microtainer® SST™ Blood Collection Tubes and allowed to clot. Clotted blood was then spun for 10 min at 10,000 xg. Clarified sera was then collected and stored at −80 °C. Prior to testing, sera was thawed and heat-inactivated at 56 °C for 30 min and debris were pelleted by spinning at 10,000 xg for 10 min in a microcentrifuge.
+ Open protocol
+ Expand
2

Murine Immunization with PapMV Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six- to 8-week-old female BALB/c mice were immunized by intramuscular injection (i.m.) twice, 2 weeks apart, with buffer (50 µL of 10 mM Tris–HCl, pH 8.0) or PapMV-SrtA-M2e, PapMV-sM2e, PapMV-SrtA-T20 or PapMV-SrtA with free T20 peptide. Blood samples were collected before each immunization on days 13 and 27. Serum was separated from the blood by centrifugation in BD Microtainer SST blood collection tubes (BD, East Rutherford, New Jersey, USA) for 2 min at 10,000×g. Total IgG and IgG2a serotype endpoint titers against M2e and T20 peptides in the sera of immunized mice were determined by enzyme linked immunosorbent assay (ELISA) as described below.
+ Open protocol
+ Expand
3

Intranasal M2e Peptide Immunogenicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six to 10 week old female BALB/c mice were immunized by intramuscular injection (i.m.) twice, 3 weeks apart. Each group contained five mice. Group 1 received control buffer (50 μL of 10 mM Tris–HCl, 150 mM NaCl pH 8.0); Group 2 received PapMV-C and free M2e peptide; Group 3 received PapMV-C coupled to M2e; Group 4 received PapMV-N and free M2e peptide; Group 5 received PapMV-N coupled to M2e. To assess the humoral response to the M2e peptide, blood samples were collected before each boost-immunization on days 20 and 42. Serum was separated from the blood by centrifugation in BD Microtainer SST blood collection tubes (BD, East Rutherford, NJ, USA) for 2 min at 10,000× g. The immunoglobulin G (IgG) 2a endpoint titer to M2e peptides in the sera of immunized mice was determined by enzyme linked immunosorbent assay (ELISA) as described previously [33 (link)]. Briefly, 96-well flat-bottom nuncTM MaxiSorp plates (VWR, Radnor, PA, USA) were coated overnight at 4 °C with the M2e peptide at 1 μg/mL. Two-fold step serial dilutions of mice sera, starting at 1 in 50, were prepared. Primary antibodies were revealed using peroxidase-conjugated goat anti-mouse IgG2a (Jackson Immunoresearch, West Grove, PA, USA). Results are expressed as antibody endpoint titers greater than threefold OD450nm of the background value consisting of a pool of pre-immune sera.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!